FluSure XP (Canada)

Company: Zoetis

Swine Influenza Vaccine, H1N1 and H3N2

Killed Virus

For use in swine only

For veterinary use only

For vaccination of healthy swine, including pregnant sows and gilts, 3 weeks of age or older as an aid in preventing respiratory disease caused by SIV subtypes H1N1 and H3N2. FluSure XP is a freeze-dried preparation containing the following isolates: A/Swine/North Carolina/031/05 (H1N1); A/Swine/Missouri/069/05 (H3N2); and A/Swine/Iowa/110600/00 (H1N1). A sterile diluent containing Amphigen^® is used to rehydrate the freeze-dried vaccine. A duration of immunity of at least 10 weeks, as demonstrated by a significant reduction in lung lesions, has been established against SIV H3N2.

Directions For Use

Shake diluent before use. Aseptically rehydrate the freeze-dried vaccine with the accompanying adjuvant-containing sterile diluent, shake well, and administer 2 mL intramuscularly. Healthy swine 3 weeks of age or older should receive two 2-mL doses administered approximately 3 weeks apart. In young pigs, vaccinate after maternally derived antibodies to SIV have declined.

Precautions

Store at 2°-7°C. Do not freeze. Use entire contents when first opened or rehydrated. Sterilized syringes and needles should be used to administer this vaccine. Do not vaccinate within 21 days before slaughter. Contains gentamicin as preservative. As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.

Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (888) 963-8471 (USA), (800) 461-0917 (Canada).

™ Trademark of Zoetis Inc., its subsidiaries or licensors; Zoetis Canada as licensee.

^® Registered trademark of Zoetis Inc., its subsidiaries or licensors; Zoetis Canada as licensee.

U.S. Veterinary License No. 190

Zoetis Inc., Kalamazoo, MI 49007, USA

NAC No.: 1198353.2